Literature DB >> 8313126

Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy.

A M Abulafi1, N S Williams.   

Abstract

Local recurrence of colorectal cancer after 'curative' surgery is a major clinical problem. Typically, 50-70 per cent of patients presenting to a surgical clinic will undergo apparently curative surgery for disease and of these about 10-25 per cent will develop local recurrence, in either the tumour bed or bowel wall. The wide differences in local recurrence rate both between and within institutions is probably caused by variation in surgical technique. The main causes of local recurrence are inadequate excision of the primary tumour or the draining lymph nodes, and intraoperative tumour cell implantation. The most significant single factor prognostic of local recurrence is Dukes' tumour stage. Other important factors include tumour grade and fixity, level of the tumour in the rectum, blood and lymphatic vessel invasion, inadvertent perforation of the tumour during resection, and the surgeon's experience. The prognosis of patients with local recurrence is poor. Prevention of recurrence by adequate surgery and adjuvant therapy as well as its early detection offer the best prospect of improving results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8313126     DOI: 10.1002/bjs.1800810106

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  51 in total

1.  Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator.

Authors:  M A Reymond; B Hu; A Garcia; T Reck; F Köckerling; J Hess; P Morel
Journal:  Surg Endosc       Date:  2000-01       Impact factor: 4.584

2.  Surgical treatment of cancer of the colon or rectum. Patient Care Committee of the Society for Surgery of the Alimentary Tract (SSAT).

Authors: 
Journal:  J Gastrointest Surg       Date:  1999 Mar-Apr       Impact factor: 3.452

3.  Inhibitory effects of EGFR antisense oligodeox ynucleotide in human colorectal cancer cell line.

Authors:  Yong He; Jun Zhou; Jin-Sheng Wu; Ke-Feng Dou
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer.

Authors:  Jen-Kou Lin; Te-Cheng Yueh; Shih-Ching Chang; Chun-Chi Lin; Yuan-Tzu Lan; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  J Gastrointest Surg       Date:  2011-10-15       Impact factor: 3.452

5.  Intensive or not surveillance of patients with colorectal cancer after curative resection.

Authors:  Gerardo Rosati
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 6.  Chemoradiotherapy for colorectal cancer.

Authors:  N Andre; W Schmiegel
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

Review 7.  Surveillance of patients following surgery with curative intent for colorectal cancer.

Authors:  Steven Gan; Katherine Wilson; Paul Hollington
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

8.  Simplification of total mesorectal excision with colonic J-pouch anal anastomosis for middle and lower rectal cancer: one surgeon's experience.

Authors:  Masato Kusunoki; Yasuhiro Inoue; Hidenori Yanagi
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

9.  Predictors of successful salvage surgery for local pelvic recurrence of rectosigmoid colon and rectal cancers.

Authors:  Akihiko Kobayashi; Masanori Sugito; Masaaki Ito; Norio Saito
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

10.  Scatter spectroscopic imaging distinguishes between breast pathologies in tissues relevant to surgical margin assessment.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Elizabeth J Rizzo; Mary C Schwab; Richard J Barth; Brian W Pogue; Keith D Paulsen; Wendy A Wells
Journal:  Clin Cancer Res       Date:  2012-08-20       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.